|Articles|September 1, 2017
- Pharmaceutical Executive-09-01-2017
- Volume 37
- Issue 9
Pharmaceutical Executive, September 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharm Exec's 16th Annual Industry Auditabout 8 years ago
The Supply Chain: What Price Patient Centricity?about 8 years ago
Drug Serialization for DSCSA Compliance Benefits Everyoneabout 8 years ago
Pharm Exec's 16th Annual Industry Audit (Overview)about 8 years ago
You Are Pharmaabout 8 years ago
Leading With Patients in Mind: Cynthia Schwalmabout 8 years ago
FDA, Industry Prepare for New User Fee Initiativesabout 8 years ago
Data Inflection Pointabout 8 years ago
UK Unveils Post-Brexit Life Sciences Strategyabout 8 years ago
Seizing the Opportunity in STEMNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
